Clinical trial

Linagliptin for Type 2 Diabetes Mellitus: A Review of the Pivotal Clinical Trials.

Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials.

Filed under: Drug and Alcohol Rehabilitation

Ther Adv Endocrinol Metab. 2012 Aug; 3(4): 113-24
McGill JB

Patients with type 2 diabetes mellitus (T2DM) frequently require multiple… Continue reading

Drug Rehab Arizona – the SUNDANCE CENTER – Arizona Drug Rehab


 

Drug Rehab Arizona – THE SUNDANCE CENTER – Arizona Drug Rehab – www.thesundancecenter.com Arizona Drug Rehab & Treatment. Because Recovery from Drug Rehab Arizona Can be tough alone, and easier together. Arizona Drug Rehab is provided by The Sundance… Continue reading

Clinical Depression: Lawrences Story


 

Clinical depression: Lawrences story – Lawrence has depression. He explains how easy it was to ignore the symptoms, despite being a psychiatric nurse, and the problem this caused in his working life

 

Eating more to help… Continue reading

[The Participation of the Nutritionist in Primary Health Care in a Large Urban Center].

[The participation of the nutritionist in Primary Health Care in a large urban center].

Filed under: Rehab Centers

Cien Saude Colet. 2012 Dec; 17(12): 3289-300
Cervato-Mancuso AM, Tonacio LV, Silva ER, Vieira VL

Nutritionists are important professionals for ensuring… Continue reading

Rehab Centers: Physical Inactivity Is Associated With Low Self Efficacy and Social Support Among Patients With Hypertension in Nigeria.

Physical inactivity is associated with low self efficacy and social support among patients with hypertension in Nigeria.

Filed under: Rehab Centers

Chronic Illn. 2012 Nov 22;
Idowu OA, Adeniyi AF, Atijosan OJ, Ogwumike OO

BACKGROUND: Physical inactivity is a… Continue reading

The EBI Enzyme Portal.

The EBI enzyme portal.

Filed under: Drug and Alcohol Rehabilitation

Nucleic Acids Res. 2012 Nov 21;
Alcántara R, Onwubiko J, Cao H, Matos PD, Cham JA, Jacobsen J, Holliday GL, Fischer JD, Rahman SA, Jassal B, Goujon M, Rowland… Continue reading

Innovative Trial Designs for Improving TB Drug Development.

Innovative trial designs for improving TB drug development.

Filed under: Drug and Alcohol Rehabilitation

J Infect Dis. 2012 Nov 21;
Dodd LE, Proschan MA

HubMed – drug

 

MPs are to investigate need for drug companies to share clinical… Continue reading

Nicotine Receptor Partial Agonists for Smoking Cessation.

Nicotine receptor partial agonists for smoking cessation.

Filed under: Addiction Rehab

Sao Paulo Med J. 2012; 130(5): 346-7
Cahill K, Stead LF, Lancaster T, Polonio IB

Nicotine receptor partial agonists may help people to stop smoking by a combination… Continue reading

Mindfulness and Bodily Distress.

Mindfulness and bodily distress.

Filed under: Depression Treatment

Dan Med J. 2012 Nov; 59(11): B4547
Fjorback LO

We have created a mindfulness approach to treat patients who experience multiple, persistent, and disabling physical symptoms that cannot be explained by a well-defined medical or surgical condition. Randomized controlled trials in this area are few, and research is hampered by the lack of clear definitions. Bodily distress syndrome (BDS) or bodily stress is an empirically defined definition unifying various conditions such as fibromyalgia, chronic fatigue syndrome, and somatization disorder. In the present PhD, we explored whether patients suffering from BDS may be committed to mental training in the form of mindfulness therapy, which is a mindfulness program specifically targeted patients suffering from BDS. The theoretical model for including mindfulness training in the treatment of BDS is based on identified neurobiological impairments in these patients and the neurobiological improvements that mindfulness training may offer. BDS is a major public health issue possibly associated with the pathology of the immuno-endocrine and autonomic nervous system. BDS patients are often stigmatized, and effective treatment is rarely delivered, which leaves these patients isolated, left by themselves, vulnerable to potentially harming medical and/or alternative treatments. Accordingly, there is a need for non-harming practical tools that patients can learn to master so that they can improve the ability to take responsibility for their own health and wellbeing. Mindfulness-Based Stress Reduction (MBSR) is a group program that employs mindfulness practice to alleviate suffering associated with physical, psychosomatic, and psychiatric disorders. Mindfulness-Based Cognitive Therapy (MBCT) is designed to prevent depressive relapse. Paper I and II present systematic literature reviews only of randomized controlled trials on MBSR and MBCT. The effect of MBSR has been explored on fibromyalgia in three studies, none of them showed convincing results, but gave some indications as to improvement. The reviews recommended MBSR as a useful method for improving mental health; however, lack of long-term follow-up and active control groups are limitations in most studies. MBCT was recommended as a tool for preventing depressive relapse in recovered, recurrently depressed patients, but the implication of MBSR and MBCT is problematic, especially due to the lack of well educated mindfulness teachers. We combined MBSR with cognitive behavioral therapy, CBT, specifically targeted BDS. Paper III provides original data from 119 patients enrolled in a randomized clinical trial, mindfulness therapy for BDS. The randomized controlled trial indicates that BDS patients are capable of and willing to engage in mindfulness therapy. This thesis showed that mindfulness therapy can safely and successfully engage BDS patients in mindfulness practice. Since individual CBT and psychiatric consultation have previously been found to have positive outcomes for BDS patients, we compared mindfulness therapy to an active control group entitled specialized treatment in which an individual treatment was planned in collaboration between the patient and an MD specialized in BDS, CBT, and psychiatry. Mindfulness therapy was comparable to specialized treatment in improving the quality of life and the symptoms of the patients with BDS at 15-month follow-up. For primary outcome physical health (PCS) at 15-month follow-up, different developments over time for the two treatment groups could not be established (F(3,2674) = 1.51, p = 0.21). However, in the mindfulness therapy group, PCS significant changed at the end of treatment and this change remained at 15-month follow-up, whereas no significantly change was seen in the specialized treatment group until at the 15-month follow-up. In the mindfulness therapy group, 26%; CI: 14-38 reported a marked improvement (> 1 SD) at the end of treatment compared with 10%; CI: 2-18 in the specialized treatment group. This amounts to a statistically… Continue reading

Sony PlayStation EyeToy Elicits Higher Levels of Movement Than the Nintendo Wii: Implications for Stroke Rehabilitation.

Sony PlayStation EyeToy elicits higher levels of movement than the Nintendo Wii: implications for stroke rehabilitation.

Filed under: Rehab Centers

Eur J Phys Rehabil Med. 2012 Nov 21;
Neil A, Ens S, Pelletier R, Jarus T, Rand D

BACKGROUND:Virtual… Continue reading